arrow
J

Jesús Palomero

University of Salamanca
H指数:17
被引数:1,546

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An investigator-initiated phase I study to assess the safety and tolerability of ex vivo next-generation neoantigen-selected tumor-infiltrating lymphocyte (TIL) therapy in advanced immune checkpoint blockade (ICB) resistant solid tumors (NEXTGENTIL-ACT)

研究者启动的I期研究,以评估体外下一代新抗原选择的肿瘤浸润淋巴细胞 (TIL) 疗法在晚期免疫检查点阻断 (ICB) 耐药实体瘤中的安全性和耐受性 (nextgentil-act)

2023-10-010
PRE
Non-replicative antibiotic resistance-free DNA vaccine encoding S and N proteins induces full protection in mice against SARS-CoV-2
2022-11-096
OAAI